The NYONRC has created numerous strong research collaborations leading to scientific advances in obesity (Exhibit IV). The focus of the Research Base (RB) is described by themes below. The use of Core Laboratories for training, consultation, and service is high. In 2005, we added the Albert Einstein College of Medicine (AECOM). The scientists added to the RB are productive investigators who have added strength to the RB. There are 76 Members. Total RB funding is $71,715,484, with 31% from NIDDK and 81% from NIH. The instructions for this grant application state that only persons at our institutions can be listed in the RB. We have a large number of collaborations with outside scientists. This actually seems the intent of the NIH Roadmap: widening collaborations for greater productivity. These relationships are multiple and growing. The NYONRC has been funded for 29 yrs. In the past decade there have been striking changes in the prevalence of obesity and its co-morbidities, with institution of more aggressive interventions, including surgery and more rationally designed pharmaceuticals and radical changes in research strategies. The latter derive from the combination of molecular cloning of rodent obesity genes, sequencing of the mouse and human genomes, introduction of transgenic manipulations, availability of massive parallel gene expression arrays, accession of powerful bioinformatics techniques for dense genetic analysis, newer brain imaging, and the advent of sophisticated methods for characterizing humans and mice for energy homeostasis phenotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK026687-33
Application #
8463159
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (J2))
Program Officer
Evans, Mary
Project Start
1996-12-01
Project End
2016-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
33
Fiscal Year
2013
Total Cost
$1,154,136
Indirect Cost
$227,471
Name
St. Luke's-Roosevelt Institute for Health Sciences
Department
Type
DUNS #
623216371
City
New York
State
NY
Country
United States
Zip Code
10019
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Blumenfeld, Nicole R; Kang, Hwan June; Fenzl, Anna et al. (2018) A direct tissue-grafting approach to increasing endogenous brown fat. Sci Rep 8:7957
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Shechter, Ari; Kim, Elijah Wookhyun; St-Onge, Marie-Pierre et al. (2018) Blocking nocturnal blue light for insomnia: A randomized controlled trial. J Psychiatr Res 96:196-202
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35
Laferrère, Blandine; Pattou, François (2018) Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 9:530
Lin, Belle Yanyu; Genden, Karma; Shen, Wei et al. (2018) The prevalence of obesity and metabolic syndrome in Tibetan immigrants living in high altitude areas in Ladakh, India. Obes Res Clin Pract 12:365-371
Heymsfield, S B; Peterson, C M; Bourgeois, B et al. (2018) Human energy expenditure: advances in organ-tissue prediction models. Obes Rev 19:1177-1188
Shah, Ankit; Levesque, Kiarra; Pierini, Esmeralda et al. (2018) Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery. Diabetes Obes Metab 20:1018-1023

Showing the most recent 10 out of 809 publications